D.A. DAVIDSON & CO. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,624
+53.6%
37,825
+15.2%
0.00%
Q2 2023$47,268
-31.4%
32,8250.0%0.00%
-100.0%
Q1 2023$68,933
+85.9%
32,825
+0.0%
0.00%
Q4 2022$37,075
-30.0%
32,8100.0%0.00%
-100.0%
Q3 2022$53,000
-10.2%
32,810
-27.6%
0.00%0.0%
Q2 2022$59,000
-33.7%
45,335
-18.0%
0.00%0.0%
Q1 2022$89,000
-21.9%
55,3100.0%0.00%0.0%
Q4 2021$114,000
-48.6%
55,310
-3.5%
0.00%
-66.7%
Q3 2021$222,000
+13.3%
57,310
-6.5%
0.00%
+50.0%
Q2 2021$196,000
+38.0%
61,310
-6.1%
0.00%0.0%
Q1 2021$142,000
-91.7%
65,310
-91.5%
0.00%
-92.3%
Q4 2020$1,719,000
-24.6%
767,321
-10.1%
0.03%
-35.0%
Q3 2020$2,279,000
-12.5%
853,716
+0.3%
0.04%
-18.4%
Q2 2020$2,604,000
+58.5%
851,101
+1.5%
0.05%
+53.1%
Q1 2020$1,643,000
-31.7%
838,265
-0.3%
0.03%
-17.9%
Q4 2019$2,405,000
-20.1%
840,948
+2.5%
0.04%
-27.8%
Q3 2019$3,010,000
-8.3%
820,158
+3.7%
0.05%
-11.5%
Q2 2019$3,282,000
-14.9%
790,874
+4.8%
0.06%
-7.6%
Q1 2019$3,855,000
+56.3%
754,355
+4.9%
0.07%
+37.5%
Q4 2018$2,466,000
-40.5%
718,923
+4.3%
0.05%
-35.1%
Q3 2018$4,143,000
-0.8%
689,278
+5.0%
0.07%
-9.8%
Q2 2018$4,175,000
+20.5%
656,527
-10.2%
0.08%
+13.9%
Q1 2018$3,466,000
+50.8%
731,300
+6.3%
0.07%
+50.0%
Q4 2017$2,298,000
+55.5%
688,153
-0.4%
0.05%
+65.5%
Q3 2017$1,478,000
-18.6%
690,960
-6.4%
0.03%
-29.3%
Q2 2017$1,816,000
-1.4%
738,500
-7.8%
0.04%
-8.9%
Q1 2017$1,841,000
+159.7%
800,590
+10.5%
0.04%
+181.2%
Q4 2016$709,000
+4.1%
724,423
+20.2%
0.02%
-5.9%
Q3 2016$681,000
-18.5%
602,731
+5.9%
0.02%
-32.0%
Q2 2016$836,000
+39.1%
569,349
+35.3%
0.02%
+31.6%
Q1 2016$601,000
-1.2%
420,810
+13.5%
0.02%
-5.0%
Q4 2015$608,000
-16.9%
370,901
+18.5%
0.02%
-23.1%
Q3 2015$732,000
+89.6%
312,886
+121.0%
0.03%
+100.0%
Q2 2015$386,000
-11.7%
141,581
+8.5%
0.01%
-7.1%
Q1 2015$437,000
+4.5%
130,500
+8.3%
0.01%0.0%
Q4 2014$418,000
-30.4%
120,500
+0.8%
0.01%
-30.0%
Q3 2014$601,000
-77.6%
119,600
-38.4%
0.02%
-78.0%
Q2 2014$2,681,000
+16.3%
194,158
+28.9%
0.09%
+11.0%
Q1 2014$2,306,000
+47.9%
150,643
-21.9%
0.08%
+41.4%
Q4 2013$1,559,000192,9500.06%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders